tiprankstipranks
Trending News
More News >
Neuren Pharmaceuticals Limited (AU:NEU)
ASX:NEU

Compare Neuren Pharmaceuticals Limited (NEU) vs. Competitors

Compare
279 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Neuren Pharmaceuticals Limited
AU$19.14
AU$2.42B
16.39
55.86%
5 Buy
0 Hold
0 Sell
Strong Buy
Clinuvel Pharmaceuticals
AU$11.08
AU$637.05M
17.57
7.63%
1 Buy
0 Hold
0 Sell
Moderate Buy
Mesoblast Limited
AU$2.64
AU$3.40B
-20.21
-3.30%
3 Buy
0 Hold
0 Sell
Strong Buy
Orthocell Ltd
AU$1.00
AU$271.31M
-27.86
-24.53%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alterity Therapeutics
AU$0.01
AU$87.00M
-5.26
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Immutep Ltd
AU$0.26
AU$648.44M
-10.43
35.38%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:NEU
Neuren Pharmaceuticals Limited
19.14
6.24
48.37%
AU:CUV
Clinuvel Pharmaceuticals
12.69
1.05
8.99%
AU:MSB
Mesoblast Limited
2.64
-0.14
-5.04%
AU:OCC
Orthocell Ltd
1.00
-0.28
-21.88%
AU:ATH
Alterity Therapeutics
0.01
>-0.01
-44.44%
AU:IMM
Immutep Ltd
0.44
0.12
37.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts